Gries Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.27M Buy
50,378
+722
+1% +$33.7K 0.36% 56
2025
Q2
$2.3M Buy
49,656
+676
+1% +$33.2K 0.42% 49
2025
Q1
$2.99M Sell
48,980
-2,267
-4% -$132K 0.58% 33
2024
Q4
$2.9M Buy
51,247
+33,832
+194% +$1.89M 0.51% 37
2024
Q3
$901K Buy
17,415
+267
+2% +$12.5K 0.17% 131
2024
Q2
$712K Sell
17,148
-50,969
-75% -$2.28M 0.15% 128
2024
Q1
$3.69M Buy
68,117
+26,338
+63% +$1.34M 0.62% 35
2023
Q4
$2.14M Sell
41,779
-1,332
-3% -$69.9K 0.47% 52
2023
Q3
$2.5M Sell
43,111
-728
-2% -$44.6K 0.67% 31
2023
Q2
$2.8M Sell
43,839
-448
-1% -$30K 0.77% 26
2023
Q1
$3.07M Sell
44,287
-1,949
-4% -$137K 0.91% 21
2022
Q4
$3.33M Buy
46,236
+8,911
+24% +$672K 1.1% 18
2022
Q3
$2.65M Buy
37,325
+707
+2% +$51.3K 1.12% 18
2022
Q2
$2.82M Sell
36,618
-10,114
-22% -$770K 1.34% 15
2022
Q1
$3.41M Buy
46,732
+9,300
+25% +$624K 1.26% 13
2021
Q4
$2.33M Buy
37,432
+18,427
+97% +$1.08M 0.95% 20
2021
Q3
$1.13M Sell
19,005
-150
-0.8% -$9.88K 0.35% 81
2021
Q2
$1.31M Hold
19,155
0.42% 67
2021
Q1
$1.25M Buy
+19,155
New +$1.19M 0.4% 72

Other funds holding BMY

Gries Financial's BMY Position: Q3 2025 in Review

Gries Financial increased its Bristol-Myers Squibb (BMY) stake by 1.5% in Q3 2025, buying an estimated $33.7K and bringing the position to 50,378 shares worth $2.27M. The position accounts for 0.36% of the portfolio, ranked #56.

Gries Financial first reported a position in BMY in Q1 2021 and has held it in 19 quarters since. The position peaked at $3.69M in Q1 2024. 2,274 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Gries Financial held 50,378 shares of Bristol-Myers Squibb worth $2.27M as of Q3 2025.
  • Gries Financial bought 722 Bristol-Myers Squibb shares in Q3 2025, an estimated $33.7K.
  • Bristol-Myers Squibb made up 0.36% of Gries Financial's portfolio in Q3 2025, its #56 holding.
  • Gries Financial first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 19 quarters since.
  • Gries Financial's Bristol-Myers Squibb position peaked at $3.69M in Q1 2024.
  • 2,274 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Gries Financial's 13F filing for Q3 2025, filed 22 Oct 2025.